Clinical Research & Reference Standard Compendium
Gut & Mucosal Panel - Scientific Literature
I. Abstract & Overview
Gut & Mucosal Panel supplies BPC-157 (5 mg), KPV (10 mg) and Thymosin Alpha-1 (10 mg) as three separately labelled lyophilized vials. The panel is organised around the epithelial barrier rather than a receptor family, combining a signaling pentadecapeptide with no identified receptor, a melanocortin-derived tripeptide with published oral nanoparticle delivery data, and a Toll-like receptor active acetylated thymic peptide. Fills are weighted by molar consumption rather than set to a matched milligram figure. Supplied for Research Use Only.
II. Chemical Specifications
| Molecular Formula | Blend — no single formula applies; BPC-157 C62H98N16O22, KPV C16H30N4O4, Thymosin Alpha-1 C129H215N33O55 |
|---|---|
| Molar Mass | BPC-157 1419.5 g/mol; KPV 342.4 g/mol; Thymosin Alpha-1 3108.3 g/mol — a ninefold spread across the tray |
| CAS Registry Number | Blend |
| Amino Acid Sequence | BPC-157 Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val; KPV Lys-Pro-Val; Thymosin Alpha-1 N-acetylated 28-residue thymic peptide |
III. Mechanism & Cellular Signaling Pathways
Thymosin Alpha-1 is an acetylated 28-residue peptide from the thymosin fraction 5 preparation, and Romani and colleagues demonstrated its activation of dendritic cells through Toll-like receptor signaling — the most clearly defined mechanism in this tray. KPV is the alpha-MSH(11-13) tripeptide, investigated as an inhibitor of NF-kappa-B activation in intestinal epithelial cells, with delivery work demonstrating retained activity in targeted nanoparticle formats. BPC-157 is a synthetic sequence derived from a gastric juice protein; no receptor has been identified and its published readouts concern nitric oxide signaling and angiogenesis rather than a characterised binding event.
IV. Primary Research Directions
- Three unrelated mechanistic approaches to the epithelial barrier in one tray — Toll-like receptor signaling, NF-kappa-B modulation, and an uncharacterised nitric oxide associated route
- KPV supplied at a 10 mg fill suited to oral delivery formulation work, the one component in this range with peer-reviewed nanoparticle delivery data behind it
- Thymosin Alpha-1 released with explicit N-terminal acetylation confirmation, since an unacetylated batch is a different molecule that still passes a purity assay
- Fills weighted by molar consumption across a three-residue to twenty-eight-residue span rather than set to a uniform milligram figure
- Written caution separating Thymosin Alpha-1 from thymalin and thymosin beta-4, three distinct substances routinely conflated across the sector
V. Frequently Asked Questions (FAQs)
Q: What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
Q: Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
Q: How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
Q: What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
Q: What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
Q: Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
Q: Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
Q: What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
VI. Academic Citations
- Xiao, B., Xu, Z., Viennois, E., et al. (2017). 'Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.' Molecular Therapy, 25(7), 1628-1640. DOI: 10.1016/j.ymthe.2016.11.020 | PMID: 28143741
- Romani, L., Bistoni, F., Gaziano, R., et al. (2004). 'Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling.' Blood, 103(11), 4232-4239. DOI: 10.1182/blood-2003-11-4036 | PMID: 14982877
- Sikiric, P., Seiwerth, S., Skrtic, A., et al. (2025). 'BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide.' Pharmaceuticals, 18(10), 1450. DOI: 10.3390/ph18101450 | PMID: 41155565
Gut & Mucosal Panel
Abstract & Overview
Gut & Mucosal Panel supplies BPC-157 (5 mg), KPV (10 mg) and Thymosin Alpha-1 (10 mg) as three separately labelled lyophilized vials. The panel is organised around the epithelial barrier rather than a receptor family, combining a signaling pentadecapeptide with no identified receptor, a melanocortin-derived tripeptide with published oral nanoparticle delivery data, and a Toll-like receptor active acetylated thymic peptide. Fills are weighted by molar consumption rather than set to a matched milligram figure. Supplied for Research Use Only.
Technical Specifications
Lot HPLC Verification
HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)
High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.
Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.
HPLC Method Conditions
| Peak | Retention Time | Area (mAU*s) | Area % |
|---|---|---|---|
| 1 (Impurity) | 2.10 | 12.5 | 0.35% |
| 2 (Gut & Mucosal Panel) | 6.40 | 3562.4 | 99.65% |
How to Read This Report: What Does This Graph Prove?
The tall spike at 6.40 minutes represents the active compound (Gut & Mucosal Panel). A single clean, tall peak confirms high concentration.
The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.
A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.
Mechanism & Signaling
Thymosin Alpha-1 is an acetylated 28-residue peptide from the thymosin fraction 5 preparation, and Romani and colleagues demonstrated its activation of dendritic cells through Toll-like receptor signaling — the most clearly defined mechanism in this tray. KPV is the alpha-MSH(11-13) tripeptide, investigated as an inhibitor of NF-kappa-B activation in intestinal epithelial cells, with delivery work demonstrating retained activity in targeted nanoparticle formats. BPC-157 is a synthetic sequence derived from a gastric juice protein; no receptor has been identified and its published readouts concern nitric oxide signaling and angiogenesis rather than a characterised binding event.
Primary Research Directions
Three unrelated mechanistic approaches to the epithelial barrier in one tray — Toll-like receptor signaling, NF-kappa-B modulation, and an uncharacterised nitric oxide associated route
KPV supplied at a 10 mg fill suited to oral delivery formulation work, the one component in this range with peer-reviewed nanoparticle delivery data behind it
Thymosin Alpha-1 released with explicit N-terminal acetylation confirmation, since an unacetylated batch is a different molecule that still passes a purity assay
Fills weighted by molar consumption across a three-residue to twenty-eight-residue span rather than set to a uniform milligram figure
Written caution separating Thymosin Alpha-1 from thymalin and thymosin beta-4, three distinct substances routinely conflated across the sector
Frequently Asked Questions
Scientific analysis and technical answers regarding the compounds.
What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
02Are these peptides intended for human consumption?
+
Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
03How does research show these peptides should be stored?
+
How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
04What is reconstitution and what solvent should be used?
+
What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
05What does the HPLC chromatogram represent?
+
What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
06Can these research compounds be combined in a single study?
+
Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
07Why is molar mass and molecular formula variance important?
+
Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
08What documentation is provided for regulatory compliance?
+
What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
Scientific Citations
Xiao, B., Xu, Z., Viennois, E., et al. (2017). 'Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.' Molecular Therapy, 25(7), 1628-1640. DOI: 10.1016/j.ymthe.2016.11.020 | PMID: 28143741
Romani, L., Bistoni, F., Gaziano, R., et al. (2004). 'Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling.' Blood, 103(11), 4232-4239. DOI: 10.1182/blood-2003-11-4036 | PMID: 14982877
Sikiric, P., Seiwerth, S., Skrtic, A., et al. (2025). 'BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide.' Pharmaceuticals, 18(10), 1450. DOI: 10.3390/ph18101450 | PMID: 41155565
Academic Disclaimer
All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.
